Nevertheless, in our study, we only assessed the total population of CD3-CD16 + 56+ NK cells as the representation of CD56bright NK cells was low in our patients, and we therefore did not consider this population suitable for a long-term assessment and statistical analysis. However, in recent years, some publications described the necessity of examination of this subpopulation.